Navigating the Drug Development Lifecycle from Bench to Bedside

Agenda Summary

I. Introduction to the Drug Development Cycle

II. The First Step: Chemical and Biologic Discovery

III. Conduct the Preclinical Testing Stage

IV. Investigational New Drug (IND) Application and Investigational Review Board (IRB) Selections: Transition from Preclinical to Clinical

V. Technology Transfer and Clinical Manufacturing

VI. Phase I - Clinical Testing

VII. Phase II - Clinical Testing

VIII. Phase III - Clinical Testing

IX. Navigate the NDA/BLA and Gain Regulatory Approval

X. Marketing and Advertising Rules and Regulations

XI. Phase IV and Post-Market Testing

XII. Keys for Successful FDA Interaction and the Future of Drug Development

Booking Options:

Register online or Call Customer Service - Tel: (866) 647-0921 or email register@pti-international.com
Group Discounts (3 or more people for this course) - Call your Course Guidance Manager at (646) 895-7447 or email CourseManager@pti-international.com
Bring this Course to Your Facility (10 or more people or further customization) - Call (800) 303-8194 or email OnSiteSolutions@pti-international.com